{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:07:38Z","timestamp":1788998858834,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctoral Research Funding"},{"name":"National Engineering Research Center for Isotopes and Drugs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01074-0","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:26:05Z","timestamp":1782390365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A clinical-radiomic model based on best subset regression for prognostic prediction in natural killer\/T-cell lymphoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Fangfang","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"1074_CR1","doi-asserted-by":"publisher","first-page":"1088685","DOI":"10.3389\/fimmu.2023.1088685","volume":"14","author":"Z Yan","year":"2023","unstructured":"Yan Z, Yao S, Wang Z, Zhou W, Yao Z, Liu Y. Treatment of extranodal NK\/T-cell lymphoma: From past to future. Front Immunol. 2023;14:1088685.","journal-title":"Front Immunol"},{"issue":"1","key":"1074_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40644-020-00379-y","volume":"21","author":"H Li","year":"2021","unstructured":"Li H, Shao G, Zhang Y, Chen X, Du C, Wang K, et al. Nomograms based on SUVmax of (18)F-FDG PET\/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer\/T-cell lymphoma. Cancer Imaging. 2021;21(1):9.","journal-title":"Cancer Imaging"},{"issue":"5","key":"1074_CR3","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s00259-024-07024-x","volume":"52","author":"C Jiang","year":"2025","unstructured":"Jiang C, Jiang Z, Zhang X, Qu L, Fu K, Teng Y, et al. Robust and interpretable deep learning system for prognostic stratification of extranodal natural killer\/T-cell lymphoma. Eur J Nucl Med Mol Imaging. 2025;52(5):1739\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1074_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3348\/kjr.2023.0618","volume":"25","author":"Y Luo","year":"2024","unstructured":"Luo Y, Huang Z, Gao Z, Wang B, Zhang Y, Bai Y, et al. Prognostic Value of (18)F-FDG PET\/CT Radiomics in Extranodal Nasal-Type NK\/T Cell Lymphoma. Korean J Radiol. 2024;25(2):189\u201398.","journal-title":"Korean J Radiol"},{"key":"1074_CR5","unstructured":"De Brabanter J, Vergote I, Verrelst H, Timmerman D, Huffel S, Vandewalle J. Univariate and multivariate regression analysis: some basic statistical principles. 1999;4:262\u201370."},{"key":"1074_CR6","doi-asserted-by":"publisher","first-page":"162580","DOI":"10.1016\/j.scitotenv.2023.162580","volume":"875","author":"D Effrosynidis","year":"2023","unstructured":"Effrosynidis D, Spiliotis E, Sylaios G, Arampatzis A. Time series and regression methods for univariate environmental forecasting: An empirical evaluation. Sci Total Environ. 2023;875:162580.","journal-title":"Sci Total Environ"},{"key":"1074_CR7","unstructured":"Smith RL. The lasso and other regularization methods in regression. 2021."},{"issue":"5","key":"1074_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ajhg.2012.03.015","volume":"90","author":"S Bhattacharjee","year":"2012","unstructured":"Bhattacharjee S, Rajaraman P, Jacobs KB, Wheeler WA, Melin BS, Hartge P, et al. A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. Am J Hum Genet. 2012;90(5):821\u201335.","journal-title":"Am J Hum Genet"},{"key":"1074_CR9","doi-asserted-by":"publisher","first-page":"924210","DOI":"10.3389\/fonc.2022.924210","volume":"12","author":"J Zhu","year":"2022","unstructured":"Zhu J, Li L, Duan Y, Wu Y, Wang X. Prognostic role of pre-treatment serum ALB in Patients with oropharyngeal cancer: A retrospective cohort study. Front Oncol. 2022;12:924210.","journal-title":"Front Oncol"},{"issue":"5","key":"1074_CR10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4251\/wjgo.v16.i5.1763","volume":"16","author":"ZR Man","year":"2024","unstructured":"Man ZR, Gong XK, Qu KL, Pang Q, Wu BQ. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia. World J Gastrointest Oncol. 2024;16(5):1763\u201372.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"1074_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s40001-023-01334-w","volume":"28","author":"C Li","year":"2023","unstructured":"Li C, Yang X, Li H, Fu Y, Wang W, Jin X, et al. Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer. Eur J Med Res. 2023;28(1):360.","journal-title":"Eur J Med Res"},{"key":"1074_CR12","doi-asserted-by":"crossref","unstructured":"Xia B, Wang X, Yang R, Mengzhen L, Yang K, Ren L, et al. Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma. Biosci Rep. 2019;39(10).","DOI":"10.1042\/BSR20190284"},{"key":"1074_CR13","doi-asserted-by":"publisher","first-page":"204062072513196","DOI":"10.1177\/20406207251319604","volume":"16","author":"M Xiong","year":"2025","unstructured":"Xiong M, Li L, Wang L, Zhu L, Chen R, He J, et al. Significance of whole-blood EBV DNA status in T\/NK-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis. Ther Adv Hematol. 2025;16:20406207251319604.","journal-title":"Ther Adv Hematol"},{"issue":"4","key":"1074_CR14","first-page":"570","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic Instruction Immun Cell. 2017;169(4):570\u201386.","journal-title":"Metabolic Instruction Immun Cell"},{"issue":"7","key":"1074_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/RLU.0000000000003590","volume":"46","author":"D Has Simsek","year":"2021","unstructured":"Has Simsek D, Civan C, Erdem S, Sanli Y. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET\/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma. Clin Nucl Med. 2021;46(7):579\u201381.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"1074_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441\u20136.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1074_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19(9):1180\u201391.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1074_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1634\/theoncologist.2015-0366","volume":"21","author":"VG Kaklamani","year":"2016","unstructured":"Kaklamani VG. Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast Cancer. Oncologist. 2016;21(8):922\u201330.","journal-title":"Oncologist"},{"issue":"16","key":"1074_CR19","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.7150\/jca.32205","volume":"10","author":"LM Hess","year":"2019","unstructured":"Hess LM, Brnabic A, Mason O, Lee P, Barker S. Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology. J Cancer. 2019;10(16):3717\u201327.","journal-title":"J Cancer"},{"issue":"11","key":"1074_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajh.24128","volume":"90","author":"TC El-Galaly","year":"2015","unstructured":"El-Galaly TC, Pedersen MB, Hutchings M, Mylam KJ, Madsen J, Gang AO, et al. Utility of interim and end-of-treatment PET\/CT in peripheral T-cell lymphomas: A review of 124 patients. Am J Hematol. 2015;90(11):975\u201380.","journal-title":"Am J Hematol"},{"key":"1074_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2407-14-153","volume":"14","author":"X He","year":"2014","unstructured":"He X, Chen Z, Fu T, Jin X, Yu T, Liang Y, et al. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. BMC Cancer. 2014;14:153.","journal-title":"BMC Cancer"},{"issue":"7","key":"1074_CR22","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1245\/s10434-024-15327-4","volume":"31","author":"C Liang","year":"2024","unstructured":"Liang C, Li D, Liang Y, Xie Y, Lin N, Guan H, et al. Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study. Ann Surg Oncol. 2024;31(7):4594\u2013604.","journal-title":"Ann Surg Oncol"},{"key":"1074_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2407-11-486","volume":"11","author":"PA Fasching","year":"2011","unstructured":"Fasching PA, Heusinger K, Haeberle L, Niklos M, Hein A, Bayer CM, et al. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer. 2011;11:486.","journal-title":"BMC Cancer"},{"issue":"7","key":"1074_CR24","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/cancers12071773","volume":"12","author":"M Porrazzo","year":"2020","unstructured":"Porrazzo M, Nicolai E, Riminucci M, Vitale C, Coscia M, De Paoli L, Rago A, Buscicchio G, Maestrini G, Ligia S, Di Prima A, Corsi A, Caronna R, Gaidano G, Mauro FR. Prognostic Significance of PET\/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. Cancers (Basel). 2020;12(7):1773.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1074_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1349-7006.2011.02164.x","volume":"103","author":"MK Song","year":"2012","unstructured":"Song MK, Chung JS, Shin HJ, Moon JH, Lee JO, Lee HS, Lee SM, Lee GW, Lee SE, Kim SJ. Prognostic value of metabolic tumor volume on PET\u200a\/\u200aCT in primary gastrointestinal diffuse large B cell lymphoma. Cancer Sci. 2012;103(3):477\u201382.","journal-title":"Cancer Sci"},{"issue":"2","key":"1074_CR26","doi-asserted-by":"publisher","first-page":"e70527","DOI":"10.1002\/cam4.70527","volume":"14","author":"X Li","year":"2025","unstructured":"Li X, Wu M, Chen M, Liu R, Tao Q, Hu Y, Yu J, Chen D. The Association Between Neutrophil-Percentage-to-Albumin Ratio (NPAR) and Mortality Among Individuals With Cancer: Insights From National Health and Nutrition Examination Survey. Cancer Med. 2025;14(2):e70527.","journal-title":"Cancer Med"},{"issue":"52","key":"1074_CR27","doi-asserted-by":"publisher","first-page":"33117","DOI":"10.1073\/pnas.2014241117","volume":"117","author":"J Zhu","year":"2020","unstructured":"Zhu J, Wen C, Zhu J, Zhang H, Wang X. A polynomial algorithm for best-subset selection problem. Proc Natl Acad Sci U S A. 2020;117(52):33117\u201323.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01074-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:08:22Z","timestamp":1788995302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01074-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01074-0","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the local Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (ZZ2025-230-01) and the Ethics Committee of Chongqing University Cancer Hospital (CZLS2025159-A). This study was conducted in accordance with the Declaration of Helsinki. Clinical trial number: not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}